Sale by James Phillips of 5050 shares of Pacific Biosciences

PACB Stock  USD 1.91  0.15  8.52%   
About 53% of Pacific Biosciences' investor base is interested to short. The analysis of overall sentiment of trading Pacific Biosciences of stock suggests that many investors are impartial at this time. The current market sentiment, together with Pacific Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Pacific Biosciences stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Pacific Biosciences Of Ca officer. General open market or private sale of non-derivative or derivative security

Read at macroaxis.com
Pacific insider trading alert for sale of common stock by James Phillips, SVP Research Development, on 12th of April 2023. This event was filed by Pacific Biosciences Of Ca with SEC on 2020-02-24. Statement of changes in beneficial ownership - SEC Form 4. James Phillips currently serves as senior vice president - research and development of Pacific Biosciences

Cash Flow Correlation

Pacific Biosciences' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Pacific Biosciences' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Pacific Biosciences Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Pacific Biosciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Pacific Biosciences Historical Investor Sentiment

Investor biases related to Pacific Biosciences' public news can be used to forecast risks associated with an investment in Pacific. The trend in average sentiment can be used to explain how an investor holding Pacific can time the market purely based on public headlines and social activities around Pacific Biosciences of. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Pacific Biosciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Pacific Biosciences and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Pacific Biosciences news discussions. The higher the estimate score, the more favorable the investor's outlook on Pacific Biosciences.

Pacific Biosciences Fundamental Analysis

We analyze Pacific Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pacific Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pacific Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Market Capitalization

Market Capitalization Comparative Analysis

Pacific Biosciences is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

Pacific Biosciences Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Pacific Biosciences stock to make a market-neutral strategy. Peer analysis of Pacific Biosciences could also be used in its relative valuation, which is a method of valuing Pacific Biosciences by comparing valuation metrics with similar companies.

Complementary Tools for Pacific Stock analysis

When running Pacific Biosciences' price analysis, check to measure Pacific Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacific Biosciences is operating at the current time. Most of Pacific Biosciences' value examination focuses on studying past and present price action to predict the probability of Pacific Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacific Biosciences' price. Additionally, you may evaluate how the addition of Pacific Biosciences to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing